Patent directory · USPTO A61K / A61P
Patents matching “sequence”
165 pharma patents match "sequence" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 165 pharmaceutical patents matching "sequence" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 12378560
Sequence multiplicity within spherical nucleic acids
granted -
US 12351839
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 12319729
Anti-Staphylococcus aureus specific antibody and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 12266425
T cell receptor sequences diagnostic for COVID-19 and related compositions
granted -
US 12221483
Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 12220446
Use of upstream open reading frame 45aa-uORF nucleotide sequence of PTEN gene and polypeptide coded by 45aa-uORF
granted -
US 12138301
Compounds including a mutant KRAS sequence and a lipid and uses thereof
granted -
US 12049479
Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
granted -
US 12012454
Anti-tumor antigen nanobody and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 12006522
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11993793
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11898207
Methods of isolating neoantigen-specific T cell receptor sequences
granted -
US 11788077
Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 11773138
Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
granted -
US 11753630
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11685784
Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 11680254
Engineered meganucleases specific for recognition sequences in the PCSK9 gene
granted -
US 11661599
CRISPR-Cas based system for targeting single-stranded sequences
granted -
US 11642366
Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy
granted -
US 11613754
Toxic RNAi active seed sequences for killing cancer cells
granted -
US 11566255
Expression of PEDV sequences in plants and plant produced vaccine for same
granted -
US 11274285
Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome
granted -
US 11266693
Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
granted